Ameratunga, Rohan, Gillis, David, Gold, Michael et al. · The journal of allergy and clinical immunology. In practice · 2017 · DOI
This study examined whether a theory called ASIA (a proposed condition blamed on vaccine adjuvants like aluminum) is supported by scientific evidence. Researchers looked at data from people who received allergen immunotherapy, which contains much more aluminum than vaccines, and found they actually had fewer autoimmune diseases, not more. The study concludes that current evidence does not support the idea that aluminum in vaccines causes autoimmune problems.
For ME/CFS patients, this is relevant because ASIA has been proposed as an etiology for ME/CFS and blamed on vaccines. Clarifying whether vaccine adjuvants actually trigger autoimmune disease is important for understanding ME/CFS pathogenesis and for informing vaccination decisions in this population. The study provides reassurance regarding vaccine safety, though it does not address whether ME/CFS itself has an autoimmune or post-vaccination basis.
This study does not prove that ME/CFS is not autoimmune, autoinflammatory, or post-vaccine-associated—only that the ASIA framework specifically and aluminum adjuvants as a mechanism lack supporting evidence. The study also does not address potential non-adjuvant vaccine mechanisms or rare individual susceptibilities. Absence of evidence for ASIA does not establish that other proposed vaccine-related pathways in ME/CFS are ruled out.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →